TB Alliance is a not-for-profit organization dedicated to the discovery, development and delivery of better, faster-acting and affordable tuberculosis drugs that are available to those who need them.
UNGA High-Level Meeting on TB
A landmark opportunity to marshal political will and resources to end TB
SimpliciTB Begins Enrollment
New trial examines potential of BPaMZ regimen to shorten TB treatment
Changing Drug-Resistant TB Treatment
TB Alliance Statement on WHO Rapid Communication Regarding MDR-TB Treatment
Engaging Civil Society at the UN
PDPs call for tripling of global investment in R&D for tuberculosis
Tomorrow's Cures
Accelerating the Pace
TB Alliance is not just developing new drugs, but changing the way TB drugs are developed.
Engaging Communities
Affordable, Accessible
TB Alliance's mission is not complete until new drugs are in the hands of those who need them.
The TB Facts
-
1.6 Million
Tuberculosis (TB) is a global pandemic, killing someone approximately every 18 seconds — about 1.6 million in 2017 alone.
The TB Pandemic » -
6-30 Months
Today's TB drug regimen takes too long to cure, is too complicated to administer, and can be toxic.
Inadequate Treatment » -
30+ Projects
Promise in the pipeline means new hope in stopping TB.
Developing Regimens »
Our Pipeline
TB Alliance manages the largest pipeline of new TB drugs in history.
